Registration of NEWGENE COVID-19 Product in the Swiss FOPH

Recently, NEWGENE COVID-19 Antigen Detection Kit is registered in the Swiss Federal Office of Public Health (FOPH), which will assist Switzerland and neighboring countries in large-scale screening. The Swiss Federal Office of Public Health (FOPH) is part of the Federal Ministry of the Interior and is responsible for Swiss public health and the development of national health policies. This registration list is widely recognized in the European Union.

In February, NEWGENE Novel Coronavirus antigen product was tested in the Dr. Risch laboratory in Switzerland. The clinical results showed that the product has good sensitivity and specificity and was recommended for Swiss market.